查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1643372

球囊瓣環成形器械的全球市場

Balloon Valvuloplasty Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 277 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球球囊瓣環成形設備市場規模將達到 27 億美元

2024 年全球氣球瓣環成形設備市場規模估計為 23 億美元，預計 2030 年將達到 27 億美元，2024-2030 年分析期間的複合年成長率為 2.8%。主動脈瓣狹窄應用是報告中分析的細分市場之一，預計其複合年成長率為 2.4%，到分析期結束時將達到 17 億美元。預計在分析期內，肺動脈狹窄應用領域的成長率將達到 3.4%。

美國市場規模估計為 6.237 億美元，中國市場預計複合年成長率為 5.2%

預計 2024 年美國球囊瓣環成形術設備市場價值將達到 6.237 億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 5.22 億美元，2024-2030 年分析期間的複合年成長率為 5.2%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 1.1% 和 2.1%。在歐洲，德國的複合年成長率預計為 1.5%。

全球球囊瓣環成形設備市場 - 主要趨勢與促進因素摘要

微創手術的進步如何促進其廣泛應用？

人們對微創治療的日益偏好極大地推動了對球囊瓣環成形設備的需求。這些裝置廣泛用於治療主動脈瓣和二尖瓣狹窄等心臟瓣膜疾病，為開胸手術提供了一種侵入性較小的替代方法。球囊瓣環成形的微創特性意味著恢復時間更快、併發症風險更低、患者預後更好，因此成為醫療保健提供者和患者的首選。

在球囊瓣環成形設備中，改進的導管設計、增強的影像引導和精確的球囊尺寸等技術創新進一步促進了球囊瓣環成形的普及。這些進步使心臟科醫生即使在複雜的情況下也能更精確地執行有效的程序。因此，隨著心血管疾病發病率的不斷上升以及對先進治療方案的需求，對這些設備的需求預計將繼續上升。

為什麼心臟瓣膜病患病率的上升會成為市場驅動力？

心臟瓣膜疾病發生率不斷上升，尤其是在老化人口中，是推動球囊瓣環成形設備市場成長的關鍵因素。隨著世界各地預期壽命的增加，主動脈瓣狹窄和瓣膜閉鎖不全等疾病變得越來越常見。這些情況通常需要及時的醫療干預，以防止心臟衰竭、中風和心臟麻痹等併發症。

球囊瓣環成形是一種有價值的治療選擇，特別是對於不適合進行手術瓣膜置換術的高風險患者。因此，世界各地的醫療機構都採用球囊瓣環成形來提供有效的治療。此外，人們對瓣膜疾病早期診斷和治療的認知不斷提高，鼓勵更多患者前往醫療機構就診，從而促進球囊瓣環成形術設備市場的發展。

技術進步如何提高設備效率？

球囊瓣環成形設備的技術進步顯著提高了其效率和安全性。製造商正專注於開發下一代設備，其特點是具有更高壓球囊、更強的機動性以及與成像系統的兼容性更強。這些改進可以實現精確的放置和擴展，從而最大限度地降低損傷周圍組織的風險。

此外，即時成像和導航系統等數位工具的整合正在徹底改變手術的精確度。這些工具可以幫助臨床醫生在手術過程中觀察和引導儀器，確保獲得最佳效果。此外，生物相容性聚合物和靈活設計等材料創新正在提高患者的舒適度並降低術後併發症的可能性。這些技術進步不僅提高了球囊瓣環成形的有效性，而且擴大了其對更廣泛患者的適用性。

哪些因素推動了球囊瓣環成形設備市場的成長？

球囊瓣環成形術設備市場的成長受到多種因素的推動，例如心臟瓣膜疾病盛行率的增加、微創技術的進步以及設備效率的持續提高。世界人口老化和心血管疾病的增加迫切需要有效的治療方案，其中氣球瓣環成形是一種重要的治療方法。

消費行為，尤其是對恢復時間短的微創手術的需求日益成長，正在塑造市場動態。先進的影像引導和改進的導管設計等技術創新透過改善程序結果進一步推動市場成長。此外，對醫療保健基礎設施的投資增加以及對瓣膜疾病早期療育益處的認知不斷提高，正在推動其廣泛應用。這些因素支撐了全球氣球瓣環成形設備市場的強勁成長軌跡。

部分

應用（主動脈瓣狹窄應用、肺動脈狹窄應用）；最終用途（醫院最終用途、門診手術中心最終用途、心導管實驗室最終用途）

受訪公司範例（43家值得關注的公司）

  • B. Braun Interventional Systems, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • BrosMed Medical Company Limited
  • Edwards Lifesciences Corporation
  • Getinge AB（Getinge Group）
  • Koninklijke Philips NV
  • Medtronic Plc
  • Stryker Corporation
  • Terumo Corporation

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲國家
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP29463

Global Balloon Valvuloplasty Devices Market to Reach US$2.7 Billion by 2030

The global market for Balloon Valvuloplasty Devices estimated at US$2.3 Billion in the year 2024, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 2.8% over the analysis period 2024-2030. Aortic Valve Stenosis Application, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Pulmonary Valve Stenosis Application segment is estimated at 3.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$623.7 Million While China is Forecast to Grow at 5.2% CAGR

The Balloon Valvuloplasty Devices market in the U.S. is estimated at US$623.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$522.0 Million by the year 2030 trailing a CAGR of 5.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.5% CAGR.

Global Balloon Valvuloplasty Devices Market - Key Trends & Drivers Summarized

How Are Advancements in Minimally Invasive Procedures Driving Adoption?

The growing preference for minimally invasive procedures is significantly propelling the demand for balloon valvuloplasty devices. These devices are widely used in the treatment of valvular heart diseases, such as aortic stenosis and mitral stenosis, offering a less invasive alternative to open-heart surgery. The minimally invasive nature of balloon valvuloplasty results in reduced recovery times, lower risk of complications, and improved patient outcomes, making it a preferred choice among healthcare providers and patients.

Technological innovations in balloon valvuloplasty devices, such as improved catheter designs, enhanced imaging guidance, and precise balloon sizing, are further contributing to their adoption. These advancements enable cardiologists to perform highly accurate and effective procedures, even in complex cases. As a result, the demand for these devices is expected to continue its upward trajectory, driven by the increasing prevalence of cardiovascular diseases and the need for advanced treatment options.

Why Is the Rising Prevalence of Valvular Heart Diseases a Key Market Driver?

The rising prevalence of valvular heart diseases, particularly among the aging population, is a critical factor driving the growth of the balloon valvuloplasty devices market. Conditions such as aortic stenosis and mitral regurgitation are becoming increasingly common as global life expectancy improves. These diseases often require timely medical intervention to prevent complications such as heart failure, stroke, or sudden cardiac arrest.

Balloon valvuloplasty is a valuable treatment option, especially for high-risk patients who are not candidates for surgical valve replacement. This has spurred healthcare facilities worldwide to adopt these devices, ensuring access to effective therapies. Additionally, increasing awareness about early diagnosis and treatment of valvular conditions is encouraging more patients to seek medical attention, thereby boosting the market for balloon valvuloplasty devices.

How Are Technological Advancements Improving Device Efficiency?

Technological advancements in balloon valvuloplasty devices are significantly enhancing their efficiency and safety. Manufacturers are focusing on developing next-generation devices with features such as high-pressure balloons, advanced steerability, and enhanced compatibility with imaging systems. These improvements enable precise placement and dilation, minimizing the risk of damage to surrounding tissues.

Moreover, the integration of digital tools, such as real-time imaging and navigation systems, is revolutionizing procedural accuracy. These tools allow clinicians to visualize and guide the device during the procedure, ensuring optimal outcomes. Additionally, innovations in materials, such as biocompatible polymers and flexible designs, are improving patient comfort and reducing the likelihood of post-procedure complications. These technological strides are not only enhancing the efficacy of balloon valvuloplasty but also expanding its application across a broader patient population.

What Factors Are Driving the Growth of the Balloon Valvuloplasty Devices Market?

The growth in the balloon valvuloplasty devices market is driven by several factors, including the increasing prevalence of valvular heart diseases, advancements in minimally invasive technologies, and ongoing improvements in device efficiency. The aging global population and the associated rise in cardiovascular conditions have created a pressing need for effective treatment options, making balloon valvuloplasty a critical intervention.

Consumer behavior, particularly the growing demand for minimally invasive procedures with shorter recovery times, is shaping market dynamics. Technological innovations, such as advanced imaging guidance and improved catheter designs, are further supporting market expansion by enhancing procedural outcomes. Additionally, increased investment in healthcare infrastructure and rising awareness about the benefits of early intervention in valvular diseases are driving adoption. These factors collectively underscore the robust growth trajectory of the global balloon valvuloplasty devices market.

SCOPE OF STUDY:

The report analyzes the Balloon Valvuloplasty Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Aortic Valve Stenosis Application, Pulmonary Valve Stenosis Application); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Labs End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • B. Braun Interventional Systems, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • BrosMed Medical Company Limited
  • Edwards Lifesciences Corporation
  • Getinge AB (Getinge Group)
  • Koninklijke Philips NV
  • Medtronic Plc
  • Stryker Corporation
  • Terumo Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Economic Frontiers: Trends, Trials & Transformations
    • Balloon Valvuloplasty Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Valvular Heart Diseases Spurs Demand for Balloon Valvuloplasty Devices
    • Technological Advancements in Minimally Invasive Cardiac Procedures Strengthen Market Growth
    • Increasing Geriatric Population Expands Addressable Market for Balloon Valvuloplasty Solutions
    • Growing Adoption of Catheter-Based Interventions Drives Demand for Advanced Valvuloplasty Devices
    • Expanding Healthcare Infrastructure in Emerging Markets Propels Market Opportunities
    • Rising Awareness About Minimally Invasive Treatment Options Accelerates Adoption Rates
    • Integration of Imaging Technologies with Valvuloplasty Devices Enhances Procedural Accuracy
    • Government Initiatives and Funding for Cardiovascular Health Strengthen Market Demand
    • Increasing Availability of Reimbursement Policies Supports Market Expansion
    • Surge in Demand for Outpatient Procedures Fuels Growth in Ambulatory Surgical Centers
    • High Burden of Congenital Heart Defects Drives Demand for Pediatric Balloon Valvuloplasty Devices
    • Innovations in Balloon Materials and Coatings Improve Device Performance and Durability
    • Expanding Focus on Personalized and Patient-Centric Treatment Approaches Drives Demand
    • Challenges in Open-Heart Surgery Propel Shift Toward Less Invasive Procedures
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Balloon Valvuloplasty Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Balloon Valvuloplasty Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Balloon Valvuloplasty Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Aortic Valve Stenosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Aortic Valve Stenosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Aortic Valve Stenosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pulmonary Valve Stenosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pulmonary Valve Stenosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Pulmonary Valve Stenosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Cardiac Catheterization Labs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Cardiac Catheterization Labs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Cardiac Catheterization Labs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Balloon Valvuloplasty Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Balloon Valvuloplasty Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Balloon Valvuloplasty Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Balloon Valvuloplasty Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • INDIA
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Balloon Valvuloplasty Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Balloon Valvuloplasty Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Balloon Valvuloplasty Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Balloon Valvuloplasty Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • AFRICA
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION